Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent
Cumulative incidence
Sirolimus
Bare-metal stent
DOI:
10.1161/circinterventions.113.000987
Publication Date:
2014-02-19T05:38:28Z
AUTHORS (43)
ABSTRACT
Late adverse events such as very late stent thrombosis (VLST) or target-lesion revascularization (TLR) after first-generation sirolimus-eluting stents (SES) implantation have not been yet fully characterized at long term in comparison with those bare-metal (BMS) implantation.Among 13 058 consecutive patients undergoing first percutaneous coronary intervention the Coronary REvascularization Demonstrating Outcome study-Kyoto registry Cohort-2, 5078 were treated SES only, and 5392 BMS only. During 7-year follow-up, VLST TLR beyond 1 year occurred constantly without attenuation 0.24% per 2.0% year, respectively. Cumulative incidence of was significantly higher group than that (1.43% versus 0.68%, P<0.0001). However, there no excess all-cause death compared (20.8% 19.6%, P=0.91). incidences (both overall clinically driven) also (12.0% 4.1%, P<0.0001 8.5% 2.6%, P<0.0001, respectively), leading to catch-up regarding through entire follow-up (18.8% 25.2%, 10.6% 10.2%, respectively). Clinical presentation acute syndrome more common time early (21.2% 10.0%).Late phenomenon pronounced BMS. This limitation should remain target for improvements DES technology.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (72)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....